Literature DB >> 17022146

Establishment and characterization of the RMG-V cell line from human ovarian clear cell adenocarcinoma.

Daisuke Aoki1, Nao Suzuki, Nobuyuki Susumu, Tomomi Noda, Atsushi Suzuki, Yutaka Tamada, Atsushi Higashiguchi, Shinji Oie, Shiro Nozawa.   

Abstract

A cell line, designated as RMG-V, was established from a patient with clear cell adenocarcinoma of the ovary. The cell line has grown without interruption and has been propagated continuously by serial passaging (more than 36 times) over 5 years. The cells are spindle-shaped, display neoplastic and pleomorphic features, and grow in a jigsaw puzzle-like arrangement while forming monolayers without contact inhibition. These cells proliferate rapidly, and the population doubling time is about 15.5 hours. The number of chromosomes ranges between 77 and 85, with a modal number of 83.

Entities:  

Mesh：

Year:  2005        PMID： 17022146     DOI： 10.1111/j.1749-0774.2005.tb00004.x

Source DB:  PubMed          Journal:  Hum Cell        ISSN： 0914-7470            Impact factor:   4.174


  7 in total

1.  Expression profiling in ovarian clear cell carcinoma: identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma.

Authors:  Akira Tsuchiya; Michiie Sakamoto; Jun Yasuda; Makoto Chuma; Tsutomu Ohta; Misao Ohki; Toshiharu Yasugi; Yuji Taketani; Setsuo Hirohashi
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

2.  Low proliferation activity may be associated with chemoresistance in clear cell carcinoma of the ovary.

Authors:  Hiroaki Itamochi; Junzo Kigawa; Toru Sugiyama; Yoshihiro Kikuchi; Mitsuaki Suzuki; Naoki Terakawa
Journal:  Obstet Gynecol       Date:  2002-08       Impact factor: 7.661

3.  HMOCC-1, a human monoclonal antibody that inhibits adhesion of ovarian cancer cells to human mesothelial cells.

Authors:  Nao Suzuki; Daisuke Aoki; Yutaka Tamada; Nobuyuki Susumu; Kimiko Orikawa; Katsumi Tsukazaki; Motoko Sakayori; Atsushi Suzuki; Takeshi Fukuchi; Makio Mukai; Kyoko Kojima-Aikawa; Isao Ishida; Shiro Nozawa
Journal:  Gynecol Oncol       Date:  2004-11       Impact factor: 5.482

4.  Establishment and characterization of cell lines derived from serous adenocarcinoma (JHOS-2) and clear cell adenocarcinoma (JHOC-5, JHOC-6) of human ovary.

Authors:  K Yamada; T Tachibana; H Hashimoto; K Suzuki; S Yanagida; H Endoh; E Kimura; M Yasuda; T Tanaka; H Ishikawa
Journal:  Hum Cell       Date:  1999-09       Impact factor: 4.174

5.  Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy.

Authors:  T Sugiyama; T Kamura; J Kigawa; N Terakawa; Y Kikuchi; T Kita; M Suzuki; I Sato; K Taguchi
Journal:  Cancer       Date:  2000-06-01       Impact factor: 6.860

6.  Establishment of a human ovarian clear cell carcinoma cell line (RMG-I) and its single cell cloning--with special reference to the stem cell of the tumor.

Authors:  S Nozawa; K Tsukazaki; M Sakayori; C H Jeng; R Iizuka
Journal:  Hum Cell       Date:  1988-12       Impact factor: 4.174

7.  A new CA125-like antigen (CA602) recognized by two monoclonal antibodies against a newly established ovarian clear cell carcinoma cell line (RMG-II).

Authors:  S Nozawa; M Yajima; H Sasaki; K Tsukazaki; D Aoki; M Sakayori; Y Udagawa; T Kobayashi; I Sato; S Furusako
Journal:  Jpn J Cancer Res       Date:  1991-07
  7 in total
  7 in total

1.  Establishment of a New Ovarian Cancer Cell Line CA5171.

Authors:  Ying-Cheng Chiang; Wen-Fang Cheng; Ming-Cheng Chang; Tzu-Pin Lu; Kuan-Ting Kuo; Hsiu-Ping Lin; Chang-Yao Hsieh; Chi-An Chen
Journal:  Reprod Sci       Date:  2014-11-12       Impact factor: 3.060

2.  Establishment and characterization of a clear cell carcinoma cell line, designated NOCC, derived from human ovary.

Authors:  Akihiro Ohyama; Junko Toyomura; Toshiaki Tachibana; Seiji Isonishi; Haruka Takahashi; Hiroshi Ishikawa
Journal:  Hum Cell       Date:  2016-08-19       Impact factor: 4.174

3.  Establishment of a new cell line of endometrioid carcinoma of the ovary and its chemosensitivity.

Authors:  Tomokazu Umezu; Hiroaki Kajiyama; Mikio Terauchi; Kiyosumi Shibata; Kazuhiko Ino; Akihiro Nawa; Fumitaka Kikkawa
Journal:  Hum Cell       Date:  2007-08       Impact factor: 4.174

4.  Establishment and molecular characterization of a human ovarian clear cell carcinoma cell line (FDOV1).

Authors:  Wei Jiang; Shuang Ye; Libing Xiang; Wentao Yang; Tiancong He; Xuan Pei; Lin Guo; Huijuan Yang
Journal:  J Ovarian Res       Date:  2018-07-09       Impact factor: 4.234

5.  Fatty acid composition and anticancer activity in colon carcinoma cell lines of Prunus dulcis seed oil.

Authors:  Filiz Mericli; Eda Becer; Hilal Kabadayı; Azmi Hanoglu; Duygu Yigit Hanoglu; Dudu Ozkum Yavuz; Temel Ozek; Seda Vatansever
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

6.  Characterization of three new serous epithelial ovarian cancer cell lines.

Authors:  Véronique Ouellet; Magdalena Zietarska; Lise Portelance; Julie Lafontaine; Jason Madore; Marie-Line Puiffe; Suzanna L Arcand; Zhen Shen; Josée Hébert; Patricia N Tonin; Diane M Provencher; Anne-Marie Mes-Masson
Journal:  BMC Cancer       Date:  2008-05-28       Impact factor: 4.430

7.  Establishment and characterization of a cell line (HCH-1) originating from a human clear cell carcinoma of the ovary.

Authors:  Takashi Yamada; Kimiaki Hattori; Hidetoshi Satomi; Tadashi Okazaki; Hiroshi Mori; Yoshinobu Hirose
Journal:  J Ovarian Res       Date:  2016-06-04       Impact factor: 4.234
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.